Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study

Cephalalgia

Volumn 16, Issue 4, 1996, Pages 257-263

  Peikert, A ^a   Wilimzig, C ^b   Kohne Volland R ^b  

^a City Hospital Munich Harlaching   (Germany)

^b NONE

Author keywords

Magnesium; Migraine; NMDA receptor; Prophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; CAFFEINE; CODEINE; ERGOTAMINE; MAGNESIUM; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SUMATRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROGNOSIS;

EID: 0030012547     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1604257.x     Document Type: Article

References (34)

1. Swanson DR. Migraine and magnesium: eleven neglected connections. Persp Biol Med 1988;31(4):526-57
2. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-301
3. Schoenen J, Sianard-Gainko J, Lenaerts M. Blood magnesium levels in migraine. Cephalalgia 1991;11:97-9
4. Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V. Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia 1992;12:21-7
5. Gallai V, Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache 1992; 32:132-5
6. Gallai V, Sarchielli P, Morucci P, Abbritti G. Red blood cell magnesium levels in migraine patients. Cephalalgia 1993;13:94-8
7. Gallai V, Sarchielli P, Morucci P, Abbritti G. Magnesium content of mononuclear blood cells in migraine patients. Headache 1994;34:160-5
8. Soriani S, Arnaldi C, De Carlo L, Arcudi D, Mazzotta D, Battistella PA, Sartori S, Abbasciano V. Serum and red blood cell magnesium levels in juvenile migraine patients. Headache 1995;35:14-6
9. Smeets MC, Vernooy CB, Souverijn JHM, Ferrari MD. Intracellular and plasma magnesium in familial hemiplegic migraine and migraine with and without aura. Cephalalgia 1994;14:29-32
10. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KMA. Low brain magnesium in migraine. Headache 1989;29:590-3
11. Jain AC, Sethi NC, Babbar PK. A clinical electroencephalographic and trace element study with special reference to zinc, copper and magnesium in serum and cerebrospinal fluid (CSF) in cases of migraine. J Neurol 1985;232 Suppl:161
12. Lauritzen M. Cortical spreading depression as a putative migraine mechanism. Trends Neurosci 1987;10:8-13
13. Welch KMA, D'Andrea G, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin 1990;8(4):817-28
14. Olesen J. Understanding the biologic basis of migraine. N Engl J Med 1994;331:1713-4
15. Altura BM, Altura BT. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neurosci Lett 1980;20:323-7
16. Turlapaty PDMV, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980;208:198-200
17. Altura BM, Altura BT, Carella A. Magnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science 1983;221:376-8
18. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984;307:462-5
19. Avoli M, Drapeau C, Louvel J, Pumain R, Olivier A, Villemure J-G. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol 1991;30:589-96
20. Mody I, Lambert JDC, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 1987;57(3):869-88
21. Baudouin-Legros M, Dard B, Guichency P. Hyperreactivity of platelets from spontaneously hypertensive rats. Role of external magnesium. Hypertension 1986;8:694-9
22. Gallai V, Sarchielli P, Franceschini M, Trequattrini A, Floridi A. Is magnesium involved in the cytokine/neurogenic inflammation in migraine? Headache 1994;34:297-8
23. Pines N, Kieff MB, Lond LMSSA. Magnesium sulphate in the treatment of angiospasm. Lancet 1933;1:577-9
24. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96
25. Diener HC. A review of current treatments for migraine. Eur Neurol 1994;34 Suppl 2:18-25
26. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia 1991;11:1-12
27. Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991;31:333-40
28. Weaver MD. Magnesium and migraine. Headache 1990;30:168
29. Wilimzig C, Latz R, Vierling W, Mutschler E, Trnovec T, Nyulassy S. Increase in magnesium plasma level after orally administered trimagnesium dicitrate. Eur J Clin Pharmacol 1996;49:317-23
30. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995;333:201-5
31. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-63
32. Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester intravenous magnesium intervention trial (LIMIT-2). Lancet 1994;343:816-9
33. Muir KW, Kennedy RL. Clinical experience with excitatory amino acid antagonist drugs. Stroke 1995;26(3):503-13
34. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache 1995;35:287-8